| John R Leyendecker, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7201 | |
| (214) 648-7732 | |
| Not Available |
| Full Name | John R Leyendecker |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033193990 | NPI | - | NPPES |
| 3810000631 | Medicaid | WV | |
| 891361K | Medicaid | NC | |
| D5072 | Other | NC | MEDCOST |
| 804390 | Other | NC | PARTNERS |
| Q0054J | Medicaid | SC | |
| 1361K | Other | NC | BCBS |
| 7801123 | Other | AETNA | |
| 10080754 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | L0377 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes - a condition known as brachydactyly. T
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
Competitive Technologies, Inc. announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT's Calmare® Pain Therapy medical device.
But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.
The researchers studied a mechanism of action they call the "magic spot" – an important regulator of gene expression. They describe their results in the current issue of the journal Cell.
› Verified 3 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes - a condition known as brachydactyly. T
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
Competitive Technologies, Inc. announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT's Calmare® Pain Therapy medical device.
But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.
The researchers studied a mechanism of action they call the "magic spot" – an important regulator of gene expression. They describe their results in the current issue of the journal Cell.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John R Leyendecker, MD Po Box 845347, Dallas, TX 75284-5347 Ph: (214) 648-7732 | John R Leyendecker, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7201 Ph: (214) 648-7732 |
News Archive
Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes - a condition known as brachydactyly. T
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
Competitive Technologies, Inc. announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT's Calmare® Pain Therapy medical device.
But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.
The researchers studied a mechanism of action they call the "magic spot" – an important regulator of gene expression. They describe their results in the current issue of the journal Cell.
› Verified 3 days ago
Dr. Nhat-long Lam Pham, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 Forest Park Rd, Dallas, TX 75390 Phone: 241-645-7615 Fax: 214-645-7624 | |
Firouzeh Arjmandi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd., Dallas, TX 75390 Phone: 214-645-3586 | |
Dr. John Debevits Iv, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3928 | |
Natalia Cabrera Almonte, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd # E6112, Dallas, TX 75390 Phone: 214-648-2054 | |
W Crysup Sory, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 12700 Park Central Dr, Ste 430, Dallas, TX 75251 Phone: 972-239-8902 Fax: 972-661-2551 | |
Jacqueline Tyra Caire, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 469-757-1000 | |
Dr. Thomas Louis Borok, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5004 Spyglass Drive, Dallas, TX 75287 Phone: 972-931-1073 Fax: 972-931-1073 |